Response Genetics, Inc. Share Price Nasdaq
Equities
US76123U1051
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2016 | Response Genetics, Inc Bankruptcy Case Dismissed | CI |
2016 | Motion for Case Dismissal Filed for Response Genetics, Inc | CI |
Sales 2013 | 19.8M 1.56B | Sales 2014 | 16.72M 1.31B | Capitalization | 12.28M 965M |
---|---|---|---|---|---|
Net income 2013 | -8M -629M | Net income 2014 | -13M -1.02B | EV / Sales 2013 | 1.92 x |
Net cash position 2013 | 6.85M 539M | Net Debt 2014 | 7.45M 585M | EV / Sales 2014 | 1.18 x |
P/E ratio 2013 |
-4.84
x | P/E ratio 2014 |
-0.9
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Roy Harris
DFI | Director of Finance/CFO | 55 | 19/08/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Roy Harris
DFI | Director of Finance/CFO | 55 | 19/08/12 |
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+41.70% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |